ArticleClinical and translational medicine2025

USP22 promotes the proliferation and Sorafenib resistance of hepatocellular carcinoma cells via its deubiquitinase activity.

Xiaochen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.